Home NDC 62332-551 DAPSONE
Product NDC 62332-551
11-digit product format 623320551
Labeler code 62332
Product ID 62332-551_d9849120-ccaa-4820-8e8d-3a8c7d809ffb
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name DAPSONE
Dosage form GEL
Route TOPICAL
Labeler Alembic Pharmaceuticals Inc.
Application ANDA213414
Marketing category ANDA
Marketing start 2026-07-01
Substance DAPSONE
Active strength 50 mg/g
Pharmacologic classes Sulfone [EPC], Sulfones [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A213414-001 DAPSONE DAPSONE 5% GEL / TOPICAL AB 2026-06-25
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A213414-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A213414-001 DAPSONE 5% GEL / TOPICAL AB 2026-06-25 84e616aacf4f…2026-08-18 06:07:40 2026-07 A213414-001 DAPSONE 5% GEL / TOPICAL AB 2026-06-25 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A213414-001 DAPSONE 5% GEL / TOPICAL AB 2026-06-25 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-09-14 22:38:34 2026-08 A213414-001 AB 1 84e616aacf4f…2026-08-18 06:07:40 2026-07 A213414-001 AB 1 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A213414-001 AB 1 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base DAPSONE
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DAPSONE 50 mg/g
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 8W5C518302 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 607295 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 62332-551-30 62332055130 1 TUBE in 1 CARTON (62332-551-30) / 30 g in 1 TUBE 1 tube 2026-07-01 No No Current 62332-551-60 62332055160 1 TUBE in 1 CARTON (62332-551-60) / 60 g in 1 TUBE 1 tube 2026-07-01 No No Current 62332-551-90 62332055190 1 TUBE in 1 CARTON (62332-551-90) / 90 g in 1 TUBE 1 tube 2026-07-01 No No Current